NCT06213038

A Clinical Study Evaluating the Safety and Efficacy of SKG0106 in Patients With Neovascular Age-related Macular Degeneration (nAMD)

CompletedPHASE1INTERVENTIONAL

Trial Details

Start: 2023-05-05Est. Completion: 2025-11-21

Enrollment target: 12 participants

Locations

Peking Union Medical College Hospital, Beijing, China
Eye & ENT Hospital of Fudan University, Shanghai, China
Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of MedicineXin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China

Eye DiseasesMacular Degeneration, WetSub-Macular Hemorrhage

The centre of the retina (macula) at the back of the eye contains cells that give us our central vision that we use for …

Bonn, GermanyEst. completion Dec 2028

Age Related Macular Degeneration

Neovascular age-related macular degeneration (nAMD), also called wet AMD, can cause serious vision loss. While anti-VEGF…

Singapore, SingaporeEst. completion Jun 2029

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.